Wedbush Issues Positive Outlook for APLS Earnings
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at Wedbush lifted their Q1 2025 EPS estimates for Apellis Pharmaceuticals in a report released on Monday, March 3rd. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.43) for the quarter, up from their previous forecast of ($0.50). […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at Wedbush lifted their Q1 2025 EPS estimates for Apellis Pharmaceuticals in a report released on Monday, March 3rd. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($0.43) for the quarter, up from their previous forecast of ($0.50). […]
